News

Oral norovirus vaccine candidate successfully tested in human challenge trial
Vaxart Inc., in collaboration with researchers from multiple academic institutions, evaluated the VXA-G1.1-NN vaccine against ...
Yahoo Finance26d
Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
Cocrystal plans to initiate a human norovirus challenge ... of CDI-988 against newly circulating major norovirus GII.17 variants. Based on a novel mechanism of action and superior broad-spectrum ...
Nasdaq25d
Cocrystal Pharma Announces Promising Results for CDI-988 as Treatment for Rising Norovirus GII.17 Strain
4, amid a surge in norovirus outbreaks in 2024-2025. The company reported positive safety and tolerability results from a Phase 1 study and plans to conduct a human challenge study in 2025 to ...
Hosted on MSN2mon
Can dogs catch norovirus? Vet explains after human cases explode
Dr Woodnutt added: "It’s worth mentioning that while it is very rare for dogs to show human norovirus, they do experience a range of stomach bugs that are specific to them. Additionally ...
Morningstar26d
Cocrystal Pharma’s Norovirus Oral Antiviral Candidate Demonstrates Potent Activity Against the Emerging GII.17 Variants
17 strains Company reported favorable safety and tolerability of CDI-988 in Phase 1 and plans to initiate a human ... major norovirus GII.17 variants. Based on a novel mechanism of action and ...